To include your compound in the COVID-19 Resource Center, submit it here.
Acetylon Pharmaceuticals Inc. (Boston, Mass.) said Celgene Corp. (NASDAQ:CELG) will acquire it for undisclosed terms. Prior to the deal's completion, Acetylon will spin out
Sign in to your BioCentury account to access your content.
Get a two-week free trial subscription to BioCentury